Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05240755 · ClinicalTrials.gov registry record · Early Phase 1
Effectiveness of Cannabidiol vs. Narcotics for Post Operative Pain Control in Elective Shoulder Arthroscopic Surgery
A Early Phase 1 study of Postoperative Pain, sponsored by Foundation for Orthopaedic Research and Education.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05240755: Completed Early Phase 1 study of Postoperative Pain, sponsored by Foundation for Orthopaedic Research and Education.
NCT05240755 is a Early Phase 1 study of Postoperative Pain that has completed, run by Foundation for Orthopaedic Research and Education. The registered enrollment target is 40 participants, below the 232-participant average among 120 other Postoperative Pain trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05240755, a Early Phase 1 study of Postoperative Pain, has completed, sponsored by Foundation for Orthopaedic Research and Education.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a prospective, randomized, nonblinded trial to evaluate the effectiveness of Cannabidiol (CBD) oil on post-operative pain control compared to opioid medications.
Primary Outcome
Numerical Pain Scale (NRS): 0 being no pain, 10 being the worst pain imaginable. Higher scores are worse outcomes.
Conditions Studied
Interventions
- DRUG Cannabidiol Oil
Study Locations (1)
Florida
- Florida Orthopaedic Institute - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2024-08-20 |
| Phase | Early Phase 1 |
What the finished NCT05240755 record still lists
NCT05240755 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 232-participant average among 120 other Postoperative Pain trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 1 intervention - of which Cannabidiol Oil is the first listed.
NCT05240755 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05240755 about?
NCT05240755 is a clinical study titled "Effectiveness of Cannabidiol vs. Narcotics for Post Operative Pain Control in Elective Shoulder Arthroscopic Surgery". This study is a prospective, randomized, nonblinded trial to evaluate the effectiveness of Cannabidiol (CBD) oil on post-operative pain control compared to opioid medications.
What is the current status of trial NCT05240755?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2022-07-01. Estimated completion is 2024-08-20.
What conditions does trial NCT05240755 study?
This clinical trial studies the following conditions: Postoperative Pain.
What interventions are being tested in trial NCT05240755?
The interventions under investigation include: Cannabidiol Oil (DRUG).
Who is sponsoring clinical trial NCT05240755?
This trial is sponsored by Foundation for Orthopaedic Research and Education, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05240755 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05240755's enrollment target sits among peer trials
40 109th of 120 higher than 10 of 120 other Postoperative Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Zynrelef vs Exparel: The Battle of Postoperative Pain Control After Robotic Sleeve Gastrectomy
RECRUITING · Early Phase 1
-
Continuous Interscalene Block Results in Superior Recovery Throughout the First Postoperative Week
COMPLETED · Early Phase 1
-
A Study of TLC590 for Postsurgical Pain Following Bunionectomy
RECRUITING · Phase 3
-
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
RECRUITING · Phase 3
-
Characterization of Acute Pain
RECRUITING
-
Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI